These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32640970)

  • 21. Attenuation of the phosphatidylinositol 3-kinase/Akt signaling pathway by Porphyromonas gingivalis gingipains RgpA, RgpB, and Kgp.
    Nakayama M; Inoue T; Naito M; Nakayama K; Ohara N
    J Biol Chem; 2015 Feb; 290(8):5190-5202. PubMed ID: 25564612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer's Mice.
    Hao X; Li Z; Li W; Katz J; Michalek SM; Barnum SR; Pozzo-Miller L; Saito T; Saido TC; Wang Q; Roberson ED; Zhang P
    Front Immunol; 2022; 13():816640. PubMed ID: 35178049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of inhibition of Porphyromonas gingivalis gingipain K by KYT-36, a potent, selective, and bioavailable peptidase inhibitor.
    Guevara T; Rodríguez-Banqueri A; Lasica AM; Ksiazek M; Potempa BA; Potempa J; Gomis-Rüth FX
    Sci Rep; 2019 Mar; 9(1):4935. PubMed ID: 30894633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gingipains may be one of the key virulence factors of Porphyromonas gingivalis to impair cognition and enhance blood-brain barrier permeability: An animal study.
    Li F; Ma C; Lei S; Pan Y; Lin L; Pan C; Li Q; Geng F; Min D; Tang X
    J Clin Periodontol; 2024 Jul; 51(7):818-839. PubMed ID: 38414291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.
    Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J
    Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human β-Defensin 3 Inhibits
    Inoue E; Minatozaki S; Katsuta Y; Nonaka S; Nakanishi H
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499428
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Olsen I; Singhrao SK
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1063-1066. PubMed ID: 32663042
    [No Abstract]   [Full Text] [Related]  

  • 28. Gingipains are the important virulence factors of Porphyromonas gingivalis downregulating B10 cells.
    Zou H; Zhou N; Cheng X; Qiu Y; Hou W; Sun J
    Mol Oral Microbiol; 2023 Aug; 38(4):275-288. PubMed ID: 37006135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis Induces Bone Loss-Correlated Alzheimer's Disease-Like Pathologies in Middle-Aged Mice.
    Gu Y; Wu Z; Zeng F; Jiang M; Teeling JL; Ni J; Takahashi I
    J Alzheimers Dis; 2020; 78(1):61-74. PubMed ID: 32925065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic Characteristics and Activities of Gingipains from Porphyromonas gingivalis.
    Kadowaki T
    Methods Mol Biol; 2021; 2210():97-112. PubMed ID: 32815131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of gingipains in the pathogenesis of periodontal disease.
    Imamura T
    J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gingipain and oncostatin M synergistically disrupt kidney tight junctions in periodontitis-associated acute kidney injury.
    Wei W; Sun J; Ji Z; Hu J; Jiang Q
    J Periodontol; 2024 Sep; 95(9):867-879. PubMed ID: 38963713
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Olsen I
    Front Neurosci; 2021; 15():691016. PubMed ID: 34720846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Distinct Immune-Stimulatory Capacities of Porphyromonas gingivalis Strains 381 and ATCC 33277 Are Determined by the
    Coats SR; Kantrong N; To TT; Jain S; Genco CA; McLean JS; Darveau RP
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Strategies Underlying Porphyromonas gingivalis Virulence.
    Lunar Silva I; Cascales E
    J Mol Biol; 2021 Apr; 433(7):166836. PubMed ID: 33539891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hTERT Peptide Fragment GV1001 Prevents the Development of
    Chen W; Kim SY; Lee A; Kim YJ; Chang C; Ton-That H; Kim R; Kim S; Park NH
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice.
    Bittner-Eddy PD; Fischer LA; Costalonga M
    Mol Oral Microbiol; 2013 Dec; 28(6):452-66. PubMed ID: 23945018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388.
    Arastu-Kapur S; Nguyen M; Raha D; Ermini F; Haditsch U; Araujo J; De Lannoy IAM; Ryder MI; Dominy SS; Lynch C; Holsinger LJ
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00562. PubMed ID: 31999052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gingipain from Porphyromonas gingivalis causes insulin resistance by degrading insulin receptors through direct proteolytic effects.
    Liu F; Zhu B; An Y; Zhou Z; Xiong P; Li X; Mi Y; He T; Chen F; Wu B
    Int J Oral Sci; 2024 Aug; 16(1):53. PubMed ID: 39085196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porphyromonas gingivalis.
    Reyes L
    Trends Microbiol; 2021 Apr; 29(4):376-377. PubMed ID: 33546976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.